Sign inJoin waitlistJoin the waitlist

Douglas Adkins

Professor, Oncology · Washington University/B-JH/SLCH Consortium

Credentials: · · ·

History

Washington University/B-JH/SLCH Consortium
Present

Medical Oncology
1989–1991
Internal Medicine
1986–1989
Boonshoft School of Medicine - Wright State University
1982–1986

Research

Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2020 · 1,128 citations
Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer…
The Lancet Oncology · 2013 · 549 citations
NCCN Guidelines Insights: Head and Neck Cancers, Version 1.2018
Journal of the National Comprehensive Cancer Network · 2018 · 468 citations

Wade Thorstad
53 papers
Peter Oppelt
47 papers
John DiPersio
45 papers
Jason Rich
39 papers · 1 as a resident
Hiram Gay
36 papers
HK
Hanna Khoury
35 papers
Ryan Jackson
34 papers · 1 as a fellow
LG
Lawrence Goodnough
30 papers
Patrik Pipkorn
30 papers · 2 as a fellow
Ravi Vij
29 papers
Randal Paniello
28 papers
BN
Brian Nussenbaum
23 papers

Clinical trials

The Minimalist Trial-2
Principal investigator · Recruiting · Phase 2
Washington University School of Medicine
2025–2033
Ramucirumab and Pembrolizumab vs Pembrolizumab Monotherapy in PD-L1 Positive Head and Neck Squamous-Cell Carcinoma
Principal investigator · Active not recruiting · Phase 2
Washington University School of Medicine
2023–2030
Palbociclib and Cetuximab Versus Cetuximab Monotherapy for Patients With CDKN2A-altered, HPV-unrelated Head and Neck Squamous Cell Carcinoma Who Experienced Disease Progression on a PD-1/L1 Inhibitor
Principal investigator · Recruiting · Phase 3
Washington University School of Medicine
2022–2029
Nab-Paclitaxel in Combination With Nivolumab to Treat Recurrent or Metastatic Head and Neck Squamous-Cell Carcinoma That Progressed on a PD-1 or PD-L1 Inhibitor
Principal investigator · Active not recruiting · Phase 2
Washington University School of Medicine
2021–2028